Antares Pharma reported $19.74M in Debt for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Adma Biologics ADMA:US $ 139.81M 1.39M
Aerie Pharmaceuticals AERI:US $ 312.13M 0.45M
Ani Pharmaceuticals ANIP:US $ 286.94M 0.21M
Becton, Dickinson and BDX:US $ 16365M 2270M
Cara Therapeutics CARA:US $ 0 0
Cerus CERS:US $ 69.74M 0.04M
Eli Lilly And LLY:US $ 16813.8M 305M
Endo International Ordinary Shares ENDP:US $ 8065.3M 25.32M
Horizon Pharma HZNP:US $ 2566.99M 1.75M
JAZZ PHA JAZZ:US $ 6021M 2.87M
Meridian Bioscience VIVO:US $ 25M 0M
Orasure Technologies OSUR:US $ 2.63M 0.28M
Pacira Pharmaceuticals PCRX:US $ 755.65M 167.77M
Revance Therapeutics RVNC:US $ 396.1M 53.64M
Sientra SIEN:US $ 70.84M 6.07M
Staar Surgical STAA:US $ 0.46M 0.03M
Supernus Pharmaceuticals SUPN:US $ 400.91M 0.53M
Teva Pharmaceutical TEVA:IT 22.08B 835M
Teva Pharmaceutical Industries TEVA:US $ 22082M 835M